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In a previous survey of 357 trimethoprim-resistant isolates of aerobic gram-negative bacteria from com-
mensal fecal flora, hybridization experiments showed that 25% (90 of 357) of the isolates failed to hybridize to
specific oligonucleotide probes for dihydrofolate reductase types 1, 2b, 3, 5, 6, 7, 8, 9, 10, and 12. Subsequent
cloning and sequencing of a plasmid-borne trimethoprim resistance gene from one of these isolates revealed
a new dihydrofolate reductase gene, dfr13, which occurred as a cassette integrated in a site-specific manner in
a class 1 integron. The gene product shared 84% amino acid identity with dfr12 and exhibited a trimethoprim
inhibition profile similar to that of dfr12. Gene probing experiments with an oligonucleotide probe specific for
this gene showed that 12.3% (44 of 357) of the isolates which did not hybridize to probes for other dihydrofolate
reductases hybridized to this probe. Immediately downstream of dfr13, a new cassette, an aminoglycoside
resistance gene of the class AADA [ANT(3()(9)-I], which encodes streptomycin-spectinomycin resistance, was
identified. This gene shares 57% identity with the consensus aadA1 (ant(3()-Ia) and has been called aadA4
(ant(3()-Id). The 3* end of the aadA4 cassette was truncated by IS26, which was contiguous with a truncated form
of Tn3. On the same plasmid, pUK2381, a second copy of IS26 was associated with sul2, which suggests that
both integrase and transposase activities have played major roles in the arrangement and dissemination of
antibiotic resistance genes dfr13, aadA4, blaTEM-1, and sul2.
Class 1 integrons are DNA elements that encode a site-
specific recombinase (intI1) of the l family of integrases and
are capable of catalyzing the insertion and recombination of
mobile DNA elements (gene cassettes) at specific sites (core
ite) with a consensus sequence, GTTRRRY. The integron
also provides a 59 conserved core site, attI1, into which gene
cassettes are preferentially inserted, and the promoters re-
sponsible for expression of the cassette-encoded genes (10, 19).
Gene cassettes are identified by a 59-base element which oc-
curs at the 39 end of the cassette and which consists of an
inverted imperfect repeat of between 50 and 150 bp which has
an inverse core site at the 59 end of the inverted repeat and a
core site at the 39 end. The insertion of a gene cassette into the
attI1 site results in the formation of a secondary site (attC)
downstream of the cassette. The attI1 site differs from attC
sites in that the inverse core site and secondary structure are
missing 59 of the attI1 core site (21). The majority of published
cassettes contain genes for resistance to various antimicrobial
agents including trimethoprim and aminoglycosides (41). Tri-
methoprim selectively inhibits the bacterial dihydrofolate re-
ductase (DHFR), thus preventing reduction of dihydrofolate
to tetrahydrofolate (11). The most common mechanism of
resistance to trimethoprim in enterobacteria is the production
of an additional plasmid-mediated DHFR which, unlike the
chromosomal enzyme, is less sensitive to inhibition by trimetho-
prim (6). Sixteen trimethoprim-resistant enzymes have been
identified in enterobacteria and have been characterized and
grouped on the basis of their sequences. With the exception of
the phylogenetic group comprising DHFR types 1, 5, 6, 7, 14, and
15 and the unusual type 2 DHFRs, the trimethoprim-resistant
DHFRs remain as diverse as chromosomal prokaryotic DHFRs
in general (1, 45). The genes for the majority of resistant DHFRs
occur as gene cassettes that are site specifically inserted into
the recombinationally active site of class 1 and class 2 integrons
(28). The high incidence of trimethoprim resistance gene cas-
settes inserted into class 1 integrons which normally harbor
sul1 (sulfonamide resistance) at the 39 end is most likely driven
by the use of trimethoprim-sulfonamide combinations, which
exert strong selection pressure for coresistance (28).
Another class of genes frequently found as cassettes in the
variable region of integrons encode aminoglycoside-modifying
enzymes which modify aminoglycosides by acetylation, adeny-
lation, or phosphorylation (41, 43). The adenylating enzymes
comprise a phylogenetically diverse group, of which only the
classes ANT(30) and ANT(9) are related (630% identity) (31,
35, 43). The ANT(30) enzymes confer streptomycin-spectino-
mycin resistance by adenylation of the 30-hydroxyl position of
streptomycin and the 9-hydroxyl position of spectinomycin,
whereas the ANT(9) class lack 30 activity and confers resis-
tance only to spectinomycin (43). The most frequently encoun-
tered ant(30) in enterobacteria is aadA1, also called (ant(30)-
Ia) (27, 43). Gene types for two other enzymes in this class have
also been established in gram-negative bacteria: aadA2 (ant(30)-
Ib), which is found on pSa in Agrobacterium tumefaciens (9)
and which shares 82% identity with aadA1, and an aadA, which
is found in Salmonella enterica serovar Choleraesuis and which
shares 44% identity with aadA1 (32). The genes aadA1 and aadA2
occur as gene cassettes and are flanked by a core sequence at
the 59 end and a 59-base element at the 39 end (9, 17).
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In a survey of trimethoprim resistance in South Africa, 357
isolates of gram-negative aerobic commensal fecal flora were
probed with oligonucleotide probes to determine the preva-
lence within the population of DHFR genes that encode tri-
methoprim resistance (3, 4). An isolate from these studies
which expressed high-level trimethoprim resistance (MIC,
$1,024 mg/liter) and which did not hybridize to any of the
DHFR probes was selected for further study. This paper re-
ports on the molecular epidemiology, nucleotide sequence, and
biochemical properties of a new DHFR gene for trimethoprim
resistance and its surrounding genetic structures which include
a new gene for streptomycin-spectinomycin resistance.
MATERIALS AND METHODS
Resistance determination. The MICs of trimethoprim were determined by the
agar dilution method; and the antibiotic sensitivity tests for detection of resis-
tance to tetracycline, ampicillin, chloramphenicol, spectinomycin, streptomycin,
and sulfisoxazole were performed by the disk diffusion method according to the
guidelines set by the National Committee for Clinical Laboratory Standards (36)
as described previously (2).
Bacterial strains and plasmids. A fecal Escherichia coli isolate, RA33-2, was
selected for this study from a group of 52 of 357 isolates which could transfer
their trimethoprim resistance determinants by conjugation to an E. coli J62-2
recipient strain (5) and which failed to hybridize to probes for dfr1, dfr2b, dfr3,
dfr5, dfr6, dfr7, dfr8, dfr9, dfr10, dfr12, and dfr14 (3). The J62-2 transconjugant
was highly resistant to trimethoprim (MIC, .2,048 mg/liter) and contained a
single plasmid pUK2381 of about 70 kb, as determined by the cumulative size of
EcoRI restriction fragments. The plasmid conferred resistance to ampicillin,
spectinomycin, streptomycin, tetracycline, sulfonamides, and trimethoprim in the
E. coli recipient. Plasmid pGEM-3Zf(1) (Promega, Madison, Wis.) was used as
a cloning vector, and E. coli JM109 (Promega) was used as a recipient in
transformation experiments. Restriction enzymes and T4 DNA ligase were sup-
plied by Boehringer Mannheim (Mannheim, Germany) and were used with the
buffers according to the manufacturer’s recommendations. Purified pUK2381
DNA was restricted with BamHI or PstI, and the fragments were ligated into
appropriately restricted pGEM-3Zf(1) DNA. The ligation mixture was electro-
transformed (16) with a Gene Pulser through a Pulse Controller (Bio-Rad
Laboratories, Richmond, Calif.) into E. coli JM109, and transformants were se-
lected on Iso-Sensitest agar containing ampicillin (50 mg/liter) and trimethoprim
(20 mg/liter). Trimethoprim-resistant transformants pUK2408 and pUK2418
contained a 3.5-kb BamHI fragment and a 4.4-kb PstI fragment, respectively.
Plasmid pUK2408 was partially restricted with EcoRI, and a 5.1-kb fragment was
religated and electrotransformed to produce trimethoprim-resistant clone
pUK2409. The 1.9-kb EcoRI-BamHI fragment containing the trimethoprim re-
sistance determinant from pUK2409 was purified and was then restricted with
HincII and PvuII. The resulting 1,225-bp PvuII-HincII fragment harbored the
trimethoprim resistance determinant and was ligated into the SmaI site of
pGEM-3Zf(1) to produce pUK2410. A restriction map of the cloned fragments
is shown in Fig. 1.
Nucleotide sequencing and analysis. Double-stranded templates of pUK2408,
pUK2409, pUK2418, and pUK2410 were isolated by an alkali lysis method with
an additional polyethylene glycol precipitation step (7). Sequencing of alkali-
denatured templates was based on the chain termination method (42), with the
SEQUENASE, version 2.0, DNA sequencing kit (United States Biochemicals,
Cleveland, Ohio) and a [35S]dATP (Amersham, Buckinghamshire, United King-
dom) label. Sequencing was performed in both directions with both dGTP and
dITP labelling mixes with M13 forward and reverse primers as well as primers
deduced from the newly sequenced DNA. Sequence comparisons were per-
formed by using the BLAST computer program (National Centre for Biological
Information) and the FASTA search program (Genetics Computer Group).
DNA hybridization protocols and Southern blotting. Plasmid DNA was ex-
tracted by a modified alkali lysis procedure as described previously (2). Chro-
mosomal DNA was isolated as described previously (7). Dot blotting and South-
ern hybridizations were performed with the DIG Oligonucleotide 39-End
labelling and detection kit (Boehinger Mannheim) as described previously (4).
The hybridization was performed for 2 h at 53°C according to the manufacturer’s
recommendations. Stringency washes were performed as described previously for
oligonucleotide probes (26).
Preparation and assay of DHFR. DHFR was prepared by ultrasonic disrup-
tion, followed by ammonium sulfate precipitation (50 to 80% fraction) and,
finally, Sephadex G-75 gel exclusion chromatography as described previously
(51). DHFR assays were performed by the method of Osborn and Huennekens
(37) as described previously (6). Estimates of the protein concentrations in crude
lysates were obtained by the method of Waddel (50).
Preparation and assay of adenyltransferase. Cells from logarithmic-phase
cultures of E. coli JM109 were harvested, washed, and resuspended in 23 assay
buffer (38). Cell extracts (50 mg of protein) from ultrasonically disrupted cells
were assayed for adenyltransferase activity by a phosphocellulose paper binding
method described previously (38). Positive and negative controls were pUK2412
(1) with aadA1 and pGEM-3Zf(1), respectively. Estimates of the protein con-
centrations in crude lysates were obtained by the method of Waddel (50).
PCR. To determine the association between the novel dfr cassette and the class
1 integron, intragenic primers for intI1 (59-CGTTCCATACAGAAGCTGG-39)
and dfr13 (59-CCATAACGACCACTTTGCTC-39) were used to amplify the re-
gion between the two genes. DNA amplification was performed in 50-ml volumes
with 2 U of Taq DNA polymerase (Promega), 1 mM MgCl2, and 0.1 mM de-
oxynucleoside triphosphates with a Hybaid (Middlesex, United Kingdom)
OmniGene thermocycler on the following cycle: denaturation at 95°C for 5 min
and then 30 cycles of 95°C for 1 min, 57°C for 1 min, and 72°C for 1 min, with a
final extension at 72°C for 5 min.
Nucleotide sequence accession number. The nucleotide sequence data re-
ported here have been assigned the accession no. Z50802 by EMBL.
RESULTS
Sequencing of a trimethoprim resistance cassette. Trimetho-
prim-resistant clone pUK2410 which contained a 1,225-bp
PvuII-HincII fragment was sequenced, and the first 573 nucle-
otides from the PvuII site on the complementary strand were
identical to those of the gene that encodes the first 191 amino
acids of the open reading frame (ORF) of the integrase gene
of class 1 integrons (intI1) (20, 46). The 59 conserved sequence
(59CS) which terminates at the attI1 core site GTTAG, which
marks the point of insertion of the first gene cassette upstream
from the start of intI1, was identical to those of class 1 inte-
grons. Eight nucleotides downstream of the 59CS a 498-bp
ORF potentially encoding a polypeptide of 165 amino acids
was identified. The start of the ORF began with an ATG start
codon at positions 718 to 720 and terminated with a TAA stop
codon at positions 1213 to 1215 (Fig. 2). No typical E. coli
ribosome binding sites were identified upstream of the ATG
start codon. A previously defined promoter region (33, 48) was
identified within the 59CS (underlined in Fig. 2). This has been
FIG. 1. Restriction map of the cloned fragments of pUK2408 and pUK2418 showing the organization and direction of transcription of intI1, dfr13, and aadA4, the
positions of insertion sequences IS1 and IS26, and the truncated sections of transposons Tn21 and Tn3. The core elements of the gene cassettes and the inverted repeats
(IRs) of the insertion sequence elements are indicated.
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FIG. 2. Nucleotide sequence and translated peptides of the PvuII-BamHI fragment of pUK2381 showing the class I integron context of gene cassettes dfr13 and
aadA4 and the position and flanking sequences of IS26. The 235 and 210 promoter regions of the 59CS are underlined, the oligonucleotide probe for dfr13 is
underlined, the points of insertion of the gene cassettes are marked (2), the imperfect inverted repeat of the 59-base element of the dfr13 cassette is underlined and
the direction is marked (.,), the inverted repeats of IS26 are in boldface type, and asterisks indicate stop codons.
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experimentally defined as a weak promoter system and is iden-
tical to the promoters found within the 59CSs of pLMO20 and
Tn5086 (46, 47). The translated polypeptide sequence was
compared with other amino acid sequences in the SwissProt
database. The 31 sequences with the best scores were all
DHFR sequences. The amino acid sequence of the new dfr
shared the highest degree of amino acid identity with dfr12
(82.4%). The degrees of identity between the dfr13 sequence
and the sequences of other resistance and chromosomal
DHFR genes ranged between 15 and 36%, thus placing dfr12
and dfr13 in an indisputable monophyletic group. The trans-
lated polypeptide for the DHFR gene is shown in Fig. 2. The
novel DHFR gene has been named dfr13, and the encoded
polypeptide has been named the type 13 DHFR. The nucleo-
tide sequence immediately 39 of the end of dfr13 encoded a
structure of 86 nucleotides which was recognizable as an attC
site (59-base element) in that it began with the inverse core site
CTAAC and terminated with the consensus core sequence
GTTAGGC. The sequence between the two core sites differed
from the sequence found between the core sites of the con-
sensus attC site in that it encoded a relatively short imperfect
inverted repeat which was positioned 15 bases to the left of the
axis of symmetry within the element and which is similar in
structure to the dfr12 cassette (24). The attC site flanking dfr13
is shown underlined in Fig. 2.
A new spectinomycin-streptomycin resistance determinant.
From pUK2408 and pUK2409, the region 39 to the DHFR
gene cassette was sequenced. Twelve nucleotides downstream
of the consensus core sequence (GTTAGGC) which marked
the end of the dfr13 cassette, an ORF of 262 amino acids was
identified. Like many other gene cassettes, there were no rec-
ognizable promoters or ribosome binding sites between the
core sequence and the first codon, and on the basis of previous
experimental evidence (15), it is presumed that the promoters
in the 59CS are adequate to ensure gene expression. The amino
acid sequence of the ORF shared 57.6% identity with AADA1,
54.6% identity with AADA2, and 44.3% identity with the
AADA from S. enterica serovar Choleraesuis. The new enzyme
also shared 37 and 27% identities with the AAD(9) adenyl-
transferases of Staphylococcus aureus and Enterococcus faeca-
lis, respectively (31, 35). The new resistance gene had adeny-
lating activity similar to that of aadA1 and was 31% more
efficient at adenylating spectinomycin (Table 1). The sequence
identity and the 30(9)-O-adenylating activity suggest that this
enzyme is of the AADA class and has been named aadA4
(ant(30)-1d), and the translated polypeptide has been named
AADA4 (ANT(30)-Id). The MIC of spectinomycin was signif-
icantly higher for the pUK2408 clone (512 mg/ml) than for the
original pUK2381 transconjugant (64 mg/ml), and this differ-
ence is most likely due to increased expression as a result of the
strong promoter and the high copy number of the cloning
vector. In contrast, the MIC of streptomycin for the pUK2381
transconjugant (128 mg/ml) was higher than that for the pUK2408
clone (64 mg/ml). A possible explanation for this discrepancy is
the presence of an additional gene for streptomycin resistance
located on pUK2381, such as strA, which is often associated
with sulII (40). The pUK2381 transconjugant was sensitive to
gentamicin, netilmicin, tobramycin, and amikacin.
aadA4, a truncated gene cassette. A truncation due to IS26
(34) was noticed 39 bases (nucleotides 2091 to 2130 in Fig. 2)
downstream of aadA4. An analysis of the sequence between
the 39 end of aadA4 and IS26 suggests that aadA4 is an atypical
cassette, since an inverse core site YYAAC, which occurs im-
mediately downstream of related cassettes aadA1 and aadA2
was absent. It is likely that aadA4 may have originally been a
functional cassette with a 59-base element located more than
39 bases downstream from the 39 end of the ORF, prior to its
interuption by the insertion of IS26. An analysis downstream of
the IS26 element showed that no sequences resembled a pu-
tative 59-base element and suggests that the 59-base element
may have been deleted from pUK2381 through recombination
with other IS26 elements.
Insertion sequences IS26 and IS1. The 39 conserved sequence
(39CS) is usually found downstream of the variable region of
class 1 integrons and contains genes that confer resistance to
intercalating dyes and quaternary ammonium compounds
(qacDE1) and sulfonamides (sul1) (39). To determine whether
the 39CS was disrupted by IS26 and is still present on pUK2381,
the nucleotide sequence downstream of IS26 was determined
and was shown to be identical to the sequence of part of the
resolvase gene (tnpR) previously identified on Tn3 and Tn1331
(14, 22) from amino acid 73 to amino acid 122 at the BamHI
site of pUK2408. Southern blotting and restriction analysis of
pUK2381 with probes for tnpR and blaTEM-1 (ScaI-BglII frag-
ment) suggest that tnpR and blaTEM-1 are contiguous and are
arranged as determined previously for the ubiquitous element
Tn3 (14, 22). Hybridization studies of pUK2381 with gene
probes consisting of the HindIII-PstI fragment sul1 and the
HindIII fragment of qacDE1 showed that neither of these two
probes hybridized to the plasmid, and therefore, the 39CS was
absent. Southern analysis with a gene probe for IS26 revealed
that two copies of the element were present on pUK2381 and
suggests that this element has played a significant role in the
arrangement of resistance genes in pUK2381 through transpo-
sition or cointegrate formation with IS26. The determinant for
sulfonamide resistance was cloned into pGEM-3Zf(1). A par-
tial sequence of this clone identified sul2 as the sulfonamide
resistance determinant. The second copy of IS26 was located
approximately 2 kb upstream of sul2. Partial sequencing and
restriction mapping 39 of intI1 revealed that the integrase was
contiguous with tnpM of Tn21 and that the downstream tnpR
was truncated by the insertion of IS1, 270 bp after the start of
tnpR (29).
Biochemical properties of DHFR type 13. The specific activ-
ities of DHFRs from crude extracts from wild-type E. coli
RA33-2 and the pUK2381 transconjugant were 4.0- and 2.6-
fold higher than that for E. coli K-12, respectively. The high
copy number and strong promoters of pGEM-3Zf(1) resulted
in a 1,000-fold increase in the level of production of DHFR in
the pUK2410 clone in comparison to that in the host chromo-
somal DHFR. The peak fraction of the type 13 DHFR from
the Sephadex G75 column was assayed in the presence of
increasing concentrations of trimethoprim and methotrexate.
The trimethoprim concentration required to inhibit the activity
of the type 13 DHFR by 50% (ID50; ID50 5 800 mM) was
100,000-fold higher than that for the E. coli JM109 chromo-
somal DHFR (ID50 5 0.007 mM). This value is similar to that
for the type 12 DHFR (ID50 5 700 mM) (24). The type 13
TABLE 1. Comparison of adenyltransferase activities of aadA1 and
aadA4 on different antibiotic substrates
Plasmida (enzyme)
Adenylating activity with various
antibiotics (cpm)b
Streptomycin Spectinomycin
pGEM-3Zf(1) (none) 0 0
pUK2408 (aadA4) 4,500 6 74 3,520 6 190
pUK2412 (aadA1) 4,540 6 140 2,420 6 150
a Plasmids were expressed in E. coli JM109.
b The reported values are the average 6 standard deviation for samples tested
in triplicate.
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DHFR was 1,700 times more resistant to inhibition by metho-
trexate (ID50 5 5 mM) than the chromosomally encoded DHFR
of E. coli JM109 (ID50 5 0.003 mM). However, the ID50 of
methotrexate was low enough relative to those of the type 2
DHFRs (ID50 5 1,000 mM) to suggest that the active site for
dihydrofolate (FH2) was not dissimilar to those of other DHFR
genes. From the Lineweaver-Burk plots, the Michaelis constant
(Km) for the type 13 DHFR was calculated to be 33.3 mM FH2,
which is one of the highest values for a resistant DHFR de-
termined and which suggests that this DHFR has a 10-fold
lower affinity for FH2 than the E. coli chromosomal DHFR
(Km 5 3.2 mM FH2). The inhibitor constants (Kis) at trimetho-
prim concentrations of 250 and 500 mM were 178 and 182 mM,
respectively (mean Ki 5 180 mM FH2), which is the highest Ki
recorded for non-type 2 DHFRs. The duration of exposure to
45°C required to inhibit DHFR activity by 50% (TD50) for the
type 13 DHFR was approximately 7 min.
Molecular epidemiology of dfr13. On the basis of the most
significant heterogeneity, a 30mer oligonucleotide probe (59-
AAGCTGGTTATAGCGCTCCTGGTTGTGCAG-39) was
derived from a comparison of the nucleotide sequences of the
closely related dfr12 and dfr13 (nucleotides 929 to 958; Fig. 2).
This heterogeneous region encodes a predicted loop between
b-sheets C and D which is based on homology with the E. coli
DHFR crystal structure (8) and overlaps the region from which
the other dfr probes were selected (3). Of the 90 of 357 isolates
of gram-negative commensal fecal flora which did not hybrid-
ize to probes for dfr1, dfr2b, dfr3, dfr5, dfr6, dfr7, dfr8, dfr9,
dfr10, dfr12, and dfr14 (3, 4), 49% (44 of 90) hybridized to the
probe for dfr13 and represented all the samples from rural and
urban populations in South Africa. Fifty-eight percent (30 of
52) of self-transmissible plasmids hybridized to the probe for
dfr13. Of the isolates which did not transfer trimethoprim
resistance to recipient strain E. coli J62-2, 37% (14 of 38)
hybridized to the probe for dfr13.
The EcoRI restriction profiles of the plasmids from the
transconjugants which harbored dfr13 showed that the majority
of the plasmids exhibited unique restriction profiles; however,
identical restriction fragments of the sequence which represent
the resistance region were common to most of the plasmids,
which suggests that a significant amount of transfer and rear-
rangement is associated with the element that harbors dfr13.
The antibiograms of the plasmids that harbor dfr13 showed
that multiple drug resistance was extremely prevalent. Most
of these plasmids conferred resistance to five or more anti-
microbial agents. Resistance to ampicillin, tetracycline, sul-
fonamides, and streptomycin was virtually ubiquitous. Specti-
nomycin resistance was found on 23 of 30 of the plasmids, and
resistance to chloramphenicol was found on 17 of 30 of the
plasmids. The MICs of trimethoprim conferred by these
plasmids were $2,048 mg/liter. To determine the associa-
tion and position of dfr13 within the integron, the region
between the two genes was amplified by PCR with a primer
pair whose sequence was from within the sequences of intI1
and dfr13. PCR products of about 700 bp were obtained from
29 of 30 of the isolates that harbored transferable plasmids and
12 of 14 of the isolates that did not transfer resistance. The size
of the PCR product suggests that the dfr13 cassette is inserted
at the intI1 site in all these isolates.
To determine the location of dfr13 in the isolates which did
not transfer resistance, plasmid and total DNAs from the hy-
bridization-positive isolates were run on an agarose gel, South-
ern blotted, and then hybridized to the dfr13 probe. dfr13 was
located on the chromosomes of 10 of 14 of these isolates and
occurred on nontransferable plasmids in the remaining 4 iso-
lates. DNAs from isolates that harbored nontransferable tri-
methoprim resistance were restricted with BamHI, Southern
blotted, and probed with the dfr13-specific probe. More than
half of the isolates (8 of 14) hybridized to a restriction frag-
ment of 3.5 kb which corresponds to that of the pUK2381
control and which suggests that intI1, dfr13, aadA4, and the
truncated version of Tn3 are arranged on the chromosome in
a manner similar to that in pUK2381. The restriction fragment
sizes of the remaining hybridization-positive isolates, which
included the PCR-negative isolates, were variable. The differ-
ences in the sizes of the restriction fragments indicate that
different flanking sequences surround dfr13.
DISCUSSION
It is speculated that trimethoprim-resistant plasmid-medi-
ated DHFRs originated as chromosomal genes that have been
taken up by recombinational exchange and transferred to com-
mensal and pathogenic organisms (45). Comparison of the
dfr12 and dfr13 cassettes shows that flanking cassette structures
of these related gene sequences share similar homologies
(81%). This suggests that the genetic divergence between these
closely related genes may not be the result of recent recruit-
ment of chromosomal dfr genes from related organisms under
selective pressure from trimethoprim but, rather, that these
genes existed and diverged as gene cassettes long before the
introduction of trimethoprim. Cassette homology has also
been observed within other phylogenetic groups of dfr cassettes
such as the type 1- and type 2-like classes. Similarly, a com-
parison of the flanking sequences of the aadA genes found in
gram-negative bacteria (Fig. 3) shows that the cassette struc-
tures of the closely related genes aadA1 and aadA2 are very
similar. There is no homology between the flanking sequences
of the aadA gene of S. enterica serovar Choleraesuis and those
of aadA1 and aadA2, which suggests that aadA may have di-
verged early on from a common ancestor before aadA1 and
aadA2 evolved as gene cassettes. In comparison, aadA4 may be
an intermediate in cassette evolution, bearing a core site at the
59 end of the gene but completely lacking any homology to a
59-base element on what remains of the 39 flanking sequence.
It is possible that in aadA4 a 59-base element may have been
present downstream of the point of insertion IS26. This would
explain the presence of this cassette in the context of a class 1
integron. This would imply that the structure of a putative
cassette of aadA4 is different from that of the consensus aadA
cassette at the 39 end.
Relative to phylogenetically related dfr cassettes, the class 1
integrons that harbor these cassettes are highly conserved,
FIG. 3. Comparison of the flanking sequences of aadA1 (17), aadA2 (9),
aadA4, and the aadA gene from S. enterica serovar Choleraesuis (S. chol) (32).
The GTT triplet of the core sequences is marked in boldface type, and the
inverted repeats of the 59-base element are underlined. Shaded areas mark the
start and stop codons.
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which suggests that the movement of dfr cassettes into these
elements is recent and is associated with the introduction of
trimethoprim as a selective agent. The use of sulfonamides for
three decades prior to the introduction of trimethoprim-sul-
fonamide combinations is most likely to have led to strong
selection pressure for class 1 integrons with a 39CS that harbors
sul1. The subsequent use of trimethoprim-sulfonamide combi-
nations has selected for the aquisition of dfr cassettes and the
predominance of coresistance associated with the class 1 inte-
grons (28). The arrangement of the genes for trimethoprim
and sulfonamide resistance in pUK2381 is unusual, in that
despite the association of dfr13 with the 59CS, the 39CS of the
integron which carries sul1 is absent and has been replaced by
sul2 outside of the integron context on the same plasmid.
Although sul2 is most frequently found on small nonconjuga-
tive resistance plasmids, its presence on large plasmids has
been observed previously (40). The presence of insert se-
quences IS26 and IS1 appears to have played a significant role
in the evolution of pUK2381, presumably through the forma-
tion of compound transposons and/or cointegration (12). As a
result, truncated forms of Tn21 and Tn3 have been combined
to produce a more contiguous region of multiple resistance. In
pUK2381, the potential for recombination by Tn3 and Tn21
has been substituted with insert sequences IS26 and IS1, and
these elements may play a role in enhancing the prevalence of
this form of multiple resistance. Southern blotting and restric-
tion analysis of isolates that harbor dfr13 on plasmids or on the
chromosome suggest that the arrangement of resistance genes,
truncated transposons, and insert sequences in this element is
not unique to pUK2381. dfr13 was shown to be fairly prevalent
and widespread in South Africa and was detected in 12.3%
(44 of 357) of the commensal fecal isolates resistant to tri-
methoprim. The successful spread of this DHFR may be due to
a strong selection advantage provided by the high incidence of
multiple drug resistance. It is difficult to predict how widely
distributed dfr13 may be in other parts of the world. However,
since this DHFR was extremely widespread in South Africa
and was detected in all the rural and urban population groups,
it is thought that this DHFR may be widely distributed in other
parts of the world and may account for a proportion of the 10
to 68% of DHFR genes which were not identified in a number
of studies (13, 23, 25, 30, 44, 49).
On the basis of the similarity between the sequence and
inhibitor profile of the type 12 and 13 DHFRs, it is clear that
these enzymes should be regarded as a monophyletic group
(family 3) since they share similar degrees of homology to that
found within the type I-like and type II-like DHFR enzyme
families. Discrimination between resistant DHFR genes within
close phylogenetic groups has often been hampered by the use
of gene probes which are not representative of regions of
adequate heterogeneity (52). The gene probing strategy used
with the collection of isolates in this study (3, 4) targets gene
regions which encode putative regions of low structural and
functional significance. These regions are therefore most likely
to be susceptible to genetic drift and therefore useful for the
detection and discrimination of new gene types. This strategy
has led to the detection of two new genes, dfr15 (1) and dfr13,
both of which share high degrees of sequence homology.
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